was.edu
Dec 10, 2024, 18:47
James Martin: Thrombosis risk among patients with breast cancer on targeted therapies
James Martin shared on LinkedIn:
“Happy to share our real-world data at ASH24 that thrombosis risk may be higher than previously thought among our patients with breast cancer on targeted therapies.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 24, 2025, 06:02
Jun 24, 2025, 05:47
Jun 24, 2025, 05:20